In colorectal cancer (CRC), a study has identified that SCG2 is linked to the infiltration of tumor immune cells, promotes M2 macrophage polarization, and correlates with the expression of immune checkpoints in CRC (Fukumoto et al., 2023). The gene discussed is SCG2; the disease is colorectal carcinoma.